WANG Jun-jie,XIU Dian-rong,RAN Wei-qiang.Iodine-125 seed implantation for unresectable pancreatic carcinoma guided by intraoperative ultrasound[J].Chinese Journal of Radiological Medicine and Protection,2005,25(5):441-443
Iodine-125 seed implantation for unresectable pancreatic carcinoma guided by intraoperative ultrasound
Received:February 25, 2005  
DOI:
KeyWords:125Ⅰ seed  Interstitial implantation  Pancreatic carcinoma
FundProject:
Author NameAffiliation
WANG Jun-jie Cancer Center, The 3 rd Hospital of Peking University, Beijing 100083, China 
XIU Dian-rong Cancer Center, The 3 rd Hospital of Peking University, Beijing 100083, China 
RAN Wei-qiang Cancer Center, The 3 rd Hospital of Peking University, Beijing 100083, China 
白静 Cancer Center, The 3 rd Hospital of Peking University, Beijing 100083, China 
朱丽红 Cancer Center, The 3 rd Hospital of Peking University, Beijing 100083, China 
刘江平 Cancer Center, The 3 rd Hospital of Peking University, Beijing 100083, China 
Hits: 3363
Download times: 2396
Abstract::
      Objective To investigate the surgical technique,efficacy and side effects of 125Ⅰ seed interstitial implantation for pancreatic carcinoma. Methods A total of 22 patients with biopsy proven unresectable adenocarcinoma of pancreas were treated with 125Ⅰ implants during laparotomy. Of them 11 patients were treated previously by a combination of bypass surgery. The stent was implanted in 2 cases 2 weeks before and 4 weeks after seed implantation. Seed needles were implanted parallelly to each other,with 1-1.5 cm apart. Mick applicator was being connected to each needle to implant seed. The radioactive activity ranged 0.40-0.70 mCi,the matched peripheral doses were 65-145 Gy. The mean number of 125Ⅰ seed was 11-78. Five cases received external beam irradiation with 3D-CRT, the doses were 39-70 Gy and 5 patients received 2 cycle of gemcitabine chemotherapy at 1000 mg/m2 on dl and d8. Results Pain was completely relieved in 12 cases,partially relieved in 2 cases,and no response was noted in one case, so the response rate was 93.33%. The median time was 2-3 d.Altogethe 27.27% of the cases died from local recurrence of pancreatic carcinoma and 50% from metastasis. The median survival time in these patients was 6 months,with a 2-year survival rate of 9.09%. The seed immigrated to liver in 3 cases.There were no serious side effects such as infection,pancreatitis,pancreatic fistula,etc. Conclusion Radioactive seed implantation was safe,high local control,mini-damage,satisfactory palliation of pain and without significant complications.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9074617  On-line:0

v
Scan QR Code
&et=2D5BB86F25F5133531502F9B24F7358F19E4616283AFE13FC476DE2CC576F6C8357D133DF4A2A81810E6493927800D17300376E9AC1E64BEBD5647267F558416856ED46926B056C3035E119B280B319F95E16D69CFC101FD2657888A98511FDAB4202BDA672E91BA&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=2DD7160C83D0ACED&aid=CA34F1CB496AF5D8&vid=&iid=94C357A881DFC066&sid=5319469C819FCFF1&eid=5824536C90612D67&fileno=20050515&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="2DD7160C83D0ACED"; var my_aid="CA34F1CB496AF5D8";